At Edwards Lifesciences, we are dedicated to providing innovative solutions for people fighting cardiovascular disease.
Through our actions, we will become trusted partners with customers, colleagues, and patients — creating a community unified in its mission to improve the quality of life around the world. Our results will benefit customers, patients, employees, and shareholders.
We will celebrate our successes, thrive on discovery, and continually expand our boundaries. We will act boldly, decisively, and with determination on behalf of people fighting cardiovascular disease.
A message from our leaders:
Edwards Lifesciences Global Integrity Program
Edwards Lifesciences Corporation (“Edwards”) is committed to the highest standards of ethical conduct. To meet this commitment, Edwards has implemented this Global Integrity Program based upon recognised government standards for effective compliance programs, including guidance published by the Office of Inspector General, U.S. Department of Health and Human Services (the “HHS-OIG Guidance”).
The purpose of this Program is to detect and prevent behaviors, such as violations of law or company policy, which could harm Edwards and the people we serve. While the implementation of such a program cannot guarantee that improper employee conduct will be entirely eliminated, it is Edwards’ expectation that employees will comply with Program requirements, including the Edwards Global Business Practice Standards (“Standards”) and the policies and procedures established in support of the Standards. In the event that Edwards becomes aware of violations of law or company policy, we will investigate the matter and, where appropriate, take disciplinary action and implement corrective measures to prevent future violations.
The fundamental elements of our Global Integrity Program are described below. In accordance with the HHS-OIG guidance, we have tailored our Program to fit the unique environment, organisational structure, resources, operations and size of our company.
Annual Compliance Declaration
Declaration for California Compliance Law
Edwards Lifesciences Corp. (Edwards) has implemented a comprehensive compliance program (the “Program”) in accordance with the Compliance Program Guidance published by the Office of Inspector General, U.S. Department of Health and Human Services (“HHS-OIG Guidance”) that, to the best of our knowledge, meets the requirements of Cal. Health and Safety Code §§ 119400-119402 (“California Law”). Although California Law references compliance with the Pharmaceutical Research and Manufacturers of America Code on Interactions with Healthcare Professionals (the “PhRMA Code”), Edwards has adopted the AdvaMed Code of Ethics on Interactions with Healthcare Professionals (“AdvaMed Code”) which is substantially similar to the PhRMA Code but which specifically addresses interactions between medical device manufacturers and healthcare professionals.
The purpose of the Program is to detect and prevent violations of law and/or company policies. As required by California Law, Edwards has established a specific annual dollar limit that applies to promotional materials, items, and activities that Edwards provides to certain recipients in California. Edwards expects its employees to follow the requirements of the program and to comply with all applicable laws, regulations and policies. However, as recognised by the HHS-OIG, it is not possible to guarantee the elimination of improper conduct.
We regularly review, assess and modify our compliance program, as necessary, to ensure its continued effectiveness.
A copy of this Declaration or a description of our Program may be obtained by calling (800) 424-3278 (request the Compliance Department) or by contacting email@example.com.
Dated: September 1, 2023
Report a concern
Edwards Lifesciences has established various methods and resources for raising ethics questions and concerns, and encourages employees to “Speak Up” if they have a question or concern. These resources are outlined in our Global Business Practice Standards. One such resource is the Edwards Integrity Helpline, a reporting resource that is available 24 hours a day, 7 days a week. It is hosted by a third party. Any matter reported through the Helpline is treated confidentially and shared only with those that need to know for purposes of an investigation and, if appropriate, corrective action. Reports can be made to the Edwards Integrity Helpline anonymously, as permitted by local law. In certain countries, anonymous reporting is prohibited and Edwards may be required to reveal a caller’s identity.
Edwards strictly prohibits retaliation against any individual who reports a concern in good faith or participates in the company’s investigation of such a concern.
The Edwards Integrity Helpline can be accessed by telephone in the U.S. by dialing 877.219.3178. Telephone numbers and instructions for employees based in other countries are published on the Edwards employee intranet. Reports to the Helpline may also be made via the internet.
Global industry codes
Providing innovative solutions for people fighting cardiovascular disease requires collaboration with health care providers. Edwards Lifesciences is committed to ethical and socially responsible business practices, and respects the obligation of health care professionals to make independent decisions regarding medical technologies. In addition to our Credo and core values of integrity and service on behalf of customers and patients around the world, Edwards has adopted industry codes of conduct that govern our interactions with health care professionals. In the United States, we play an active role in the Advanced Medical Technology Association (AdvaMed), and have adopted the AdvaMed Code of Ethics on Interactions with Health Care Professionals. Outside the United States, we have adopted similar codes of conduct. To learn more about these medical technology associations and the codes we have adopted, you may visit the websites listed above.